Tools

LEADER 02456nam 2200517 i 4500

001 on1029858169;

003 OCoLC;

005 20210513132630.0;

006 m o d f ;

007 cr u||||||||||;

008 180202s2017 dcua on f000 0 eng ;

035 a| (Sirsi) o1029858169;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0985-A-12 (online);

086 0 a| VA 1.107/3:EN 2;

100 1 a| Low, Allison,e| author.=| ^A1377279;

245 10 a| Comparative clinical and economic effectiveness of anti-vascular endothelial growth factor agents /c| Allison Low [and seven others].;

246 17 a| Comparative clinical and economic effectiveness of anti-VEGF agents;

264 1 a| Washington, DC :b| Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service,c| January 2017.;

300 a| 1 online resource (iv, 123 pages) :b| illustrations.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| Evidence-based synthesis program;

500 a| "January 2017.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references (pages 76-81).;

536 a| VA ESPf| 05-225;

588 a| Description based on online resource; title from PDF cover (VA, viewed December 23, 2020).;

650 0 a| Vision disordersz| United States.=| ^A3700;

650 0 a| Vascular endothelial growth factorsx| Antagonists.=| ^A1234329;

650 0 a| Veteransx| Medical carez| United States.=| ^A101348;

650 0 a| Outcome assessment (Medical care)z| United States.=| ^A1006293;

710 2 a| Portland VA Medical Center.b| Evidence-based Synthesis Program Center.=| ^A1212022;

710 2 a| Quality Enhancement Research Initiative (U.S.)=| ^A631177;

830 0 a| Evidence-based synthesis program (Series)=| ^A1031189;

856 40 u| https://purl.fdlp.gov/GPO/gpo149532;

922 a| UNREPORTEDPUBSSTAFF;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5635057;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5635057-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 6/10/2021x| EDOCUMENTz| JERESOURCE;

Comparative clinical and economic effectiveness of anti-vascular endothelial growth factor agents / Allison Low [and seven others].

Author/creator	Low, Allison author.
Other author	United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body.
Other author	Portland VA Medical Center. Evidence-based Synthesis Program Center.
Other author	Quality Enhancement Research Initiative (U.S.)
Format	Electronic
Publication	Washington, DC : Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service, January 2017.
Description	1 online resource (iv, 123 pages) : illustrations.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo149532
Subjects	Vision disorders--United States. Vascular endothelial growth factors--Antagonists. Veterans--Medical care. --United States. Outcome assessment (Medical care)--United States.

Running title	Comparative clinical and economic effectiveness of anti-VEGF agents
Series	Evidence-based synthesis program Evidence-based synthesis program (Series) ^A1031189
General note	"January 2017."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references (pages 76-81).
Funding information	VA ESP 05-225
Source of description	Description based on online resource; title from PDF cover (VA, viewed December 23, 2020).
GPO item number	0985-A-12 (online)
Govt. docs number	VA 1.107/3:EN 2

Comparative clinical and economic effectiveness of anti-vascular endothelial growth factor agents / Allison Low [and seven others].

Click here for more information about this title